Milim Kim

Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance

Jae Moon Gwak, Milim Kim, Hyun Jeong Kim et al. · Oncotarget · 2017 · 84 citations · Full text

Microinvasive Carcinoma versus Ductal Carcinoma<i>In Situ</i>: A Comparison of Clinicopathological Features and Clinical Outcomes

Milim Kim, Hyun Jeong Kim, Yul Ri Chung et al. · Journal of Breast Cancer · 2018 · 62 citations · Full text

Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast

Milim Kim, Yul Ri Chung, Hyun Jeong Kim et al. · Breast Cancer Research · 2020 · 60 citations · Full text

Benign Intraductal Papilloma without Atypia on Core Needle Biopsy Has a Low Rate of Upgrading to Malignancy after Excision

Song-Hee Han, Milim Kim, Yul Ri Chung et al. · Journal of Breast Cancer · 2018 · 56 citations · Full text

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast

Milim Kim, Hye Yeon Choi, Ji Won Woo et al. · Scientific Reports · 2021 · 50 citations · Full text